Literature DB >> 7505063

5-HT3 receptors which modulate [3H]5-HT release in the guinea pig hypothalamus are not autoreceptors.

P Blier1, P J Monroe, C Bouchard, D L Smith, D J Smith.   

Abstract

The 5-HT3 agonist 2-methyl-5-HT had previously been shown to enhance the electrically evoked release of [3H]5-HT from preloaded slices of the guinea pig brain. In the present study, 2-methyl-5-HT (1 microM) was also found to increase the K+ evoked release of [3H]5-HT from preloaded slices of the guinea pig hypothalamus and this effect was blocked by the selective 5-HT3 antagonist ondansetron. In the presence of tetrodotoxin, the enhancement of the K(+)-evoked release of [3H]5-HT by 2-methyl-5-HT in hypothalamus slices was blocked, thus suggesting that the 5-HT3 receptors mediating this effect are not located directly on 5-HT terminals. In agreement with this, 2-methyl-5-HT did not alter the K(+)-evoked release of [3H]5-HT in a synaptosomal preparation of the same brain structure, even at a concentration 10-fold greater than that used in the slices. Taken together, these data indicate that these facilitatory 5-HT3 receptors are not located on 5-HT terminals in the guinea pig hypothalamus and therefore are not autoreceptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7505063     DOI: 10.1002/syn.890150206

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  3 in total

1.  Functional characterization of 5-HT1D autoreceptors on the modulation of 5-HT release in guinea-pig mesencephalic raphe, hippocampus and frontal cortex.

Authors:  M el Mansari; P Blier
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

2.  Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs.

Authors:  P Blier; C Bouchard
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

3.  The pharmacology of the neurochemical transmission in the midbrain raphe nuclei of the rat.

Authors:  L G Harsing
Journal:  Curr Neuropharmacol       Date:  2006-10       Impact factor: 7.363

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.